Results hosted on duckduckgo.com
Main navigation
-
Data
Open related submenu
Data
Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
Latest data
-
Countries
Open related submenu
Countries
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
-
Topics
Open related submenu
Selected topics
-
Best practice
Open related submenu
Best practice
The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses.
In this section
-
Activities
Open related submenu
Activities
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Selected areas
Partners and cooperation
-
Publications
Open related submenu
Publications
Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it.
In this section
Featured publications
-
Events
Open related submenu
-
News
Open related submenu
Recent news
- A new network of forensic and toxicology laboratories to strengthen EU preparedness on drugs
- Cooperation with Chile enhanced through new Working Arrangement with SENDA
- EU Drugs Agency signs Working Arrangement with Montenegro
- EUDA gets set for Lisbon Addictions 2024
- Building future-proof early-warning systems in Latin American and Caribbean countries through foresight training
- Registration opens for European Drugs Winter and Summer Schools 2025
-
About
Open related submenu
About the EUDA
We are your source of drug-related expertise in Europe. We prepare and share independent, scientifically validated knowledge, alerts and recommendations.
In this section